Opportunity ID: 320673

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DA-20-026
Funding Opportunity Title: Targeting Inflammasomes in Substance Abuse and HIV (R01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.279 — Drug Abuse and Addiction Research Programs
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Sep 17, 2019
Last Updated Date: Sep 17, 2019
Original Closing Date for Applications: Jan 15, 2020
Current Closing Date for Applications: Jan 15, 2020
Archive Date: Feb 20, 2020
Estimated Total Program Funding:
Award Ceiling:
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
For profit organizations other than small businesses
Small businesses
County governments
City or township governments
Private institutions of higher education
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Independent school districts
State governments
Special district governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV infection. Understanding the involvement of inflammasomes in virus and drug-induced immune activation may help identify molecular markers and CNS immune cells associated with HIV-1 infection or disease progression among substance abuse populations, as well as identify novel therapies to target inflammasome activation or suppression to treat neuroinflammation and immune dysregulation aroused in these processes.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-20-026.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
Email: FBOWebmaster@OD.NIH.GOV
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-E FORMS-E PKG00255058 Dec 15, 2019 Jan 15, 2020 View

Package 1

Mandatory forms

320673 RR_SF424_2_0-2.0.pdf

320673 PHS398_CoverPageSupplement_4_0-4.0.pdf

320673 RR_OtherProjectInfo_1_4-1.4.pdf

320673 PerformanceSite_2_0-2.0.pdf

320673 RR_KeyPersonExpanded_2_0-2.0.pdf

320673 PHS398_ResearchPlan_4_0-4.0.pdf

Optional forms

320673 RR_Budget_1_4-1.4.pdf

320673 RR_SubawardBudget30_1_4-1.4.pdf

320673 PHS398_ModularBudget_1_2-1.2.pdf

320673 PHS_AssignmentRequestForm_2_0-2.0.pdf

2025-07-09T09:13:11-05:00

Share This Post, Choose Your Platform!

About the Author: